University of Southern California, Keck School of Medicine
, Los Angeles, California 90033
sdiaz@genome2.hsc.usc.edu
The first Phase II clinical trial to study the combination of a
replicating viral agent with chemotherapy indicates that cancer gene therapy
may finally be on the road to success. (
879−885).